On 13 February 2025, the District Court of Rotterdam ruled in favour of the Netherlands Authority for Consumers and Markets (ACM) regarding the appeal filed by pharmaceutical company Leadiant. The court affirmed the decision to fine the manufacturer for its abuse of a dominant market position, specifically for charging prices…
